Catalyst Pharmaceuticals, Inc. CPRX Фондовый прогноз
ИИ-прогноз цены и анализ для Catalyst Pharmaceuticals, Inc. · Обновленный Апр 01, 2026
ИИ-прогноз на 90 дней
КУПИТЬ
7 дней
30 дней
90 дней
Уверенность AI: 14% Корреляция Спирмена
Апрель 01, 2026
Посмотреть точную целевую цену CPRX
Создайте бесплатный аккаунт, чтобы разблокировать ИИ-прогнозы для более 4 000 акций
Зарегистрируйтесь бесплатно через Google✓ Бесплатный аккаунт · ✓ Пробный период 30 дней · ✓ Отмена в любое время
График цен
Загрузка графика...
Ключевые показатели
Рыночная капитализация
$3.04B
Коэффициент P/E
14,2x
Коэффициент P/B
3,19x
EPS
$1,72
ROE
22,6%
Чистая маржа
385,3%
Выручка
$588M
Коэффициент текущей ликвидности
9,64x
Коэффициент D/E
0,02x
О сайте Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. (CPRX) работает в секторе Life Sciences, в частности в отрасли Pharmaceutical Preparations. В компании работает около 71 сотрудников.
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company based in Coral Gables, Florida, United States. The company develops medicines for rare diseases, including the phosphate salt of amifampridine for the treatment of Lambert–Eaton myasthenic syndrome (LEMS). The drug is referred to under the trade name Firdapse, which was approved by the FDA for approved use in children 6 years and older with LEMS in addition to the prior approval for use in adults with LEMS on November 28, 2018. Firdapse commercially …
Pharmaceutical Preparations Сопоставимые компании
| Компания | Тикер | ИИ-сигнал | Рыночная капитализация | P/E |
|---|---|---|---|---|
| Aardvark Therapeutics, Inc. | AARD | ██% | $88M | -x |
| Abbvie Inc. | ABBV | ██% | $379.29B | 89,8x |
| Abcellera Biologics Inc. | ABCL | ██% | $1.07B | -5,3x |
| Abeona Therapeutics Inc. | ABEO | ██% | $266M | 3,7x |
| Abbott Laboratories | ABT | ██% | $179.36B | 27,5x |
| Arbutus Biopharma Corp | ABUS | ██% | $865M | -8,3x |
| Abvc Biopharma, Inc. | ABVC | ██% | $26M | -0,3x |
| Abivax S.A. | ABVX | ██% | $9.25B | -x |
| Acadia Pharmaceuticals Inc | ACAD | ██% | $3.78B | 9,7x |
| Adicet Bio, Inc. | ACET | ██% | $66M | -0,4x |
| Aclaris Therapeutics, Inc. | ACRS | ██% | $485M | -4,5x |
| Acrivon Therapeutics, Inc. | ACRV | ██% | $57M | -2,8x |
| Actuate Therapeutics, Inc. | ACTU | ██% | $120M | -x |
| Accustem Sciences Inc. | ACUT | ██% | $6M | -x |
| Acurx Pharmaceuticals, Inc. | ACXP | ██% | $11M | -0,8x |
| Adagene Inc. | ADAG | ██% | $210M | -x |
| Adc Therapeutics Sa | ADCT | ██% | $478M | -9,2x |
| Adial Pharmaceuticals, Inc. | ADIL | ██% | $3M | -0,1x |
| Aditxt, Inc. | ADTX | ██% | $450K | 0,0x |
| Addex Therapeutics Ltd. | ADXN | ██% | $8M | -x |
| Aeon Biopharma, Inc. | AEON | ██% | $25M | 6,4x |
| Agios Pharmaceuticals, Inc. | AGIO | ██% | $1.99B | 3,7x |
| Ainos, Inc. | AIMD | ██% | $8M | -0,4x |
| Akebia Therapeutics, Inc. | AKBA | ██% | $376M | -5,4x |
| Akero Therapeutics, Inc. | AKRO | ██% | $4.38B | -8,7x |
| Akari Therapeutics Plc | AKTX | ██% | $5M | -2,0x |
| Aldeyra Therapeutics, Inc. | ALDX | ██% | $104M | -5,1x |
| Alkermes Plc. | ALKS | ██% | $5.70B | 23,6x |
| Allarity Therapeutics, Inc. | ALLR | ██% | $18M | -0,2x |
| Alumis Inc. | ALMS | ██% | $2.94B | -x |
| Alnylam Pharmaceuticals, Inc. | ALNY | ██% | $43.65B | 139,1x |
| Altimmune, Inc. | ALT | ██% | $405M | -5,7x |
| Alx Oncology Holdings … | ALXO | ██% | $264M | -0,4x |
| Alzamend Neuro, Inc. | ALZN | ██% | $4M | -0,1x |
| Amylyx Pharmaceuticals, Inc. | AMLX | ██% | $1.56B | -1,5x |
| Amphastar Pharmaceuticals, Inc. | AMPH | ██% | $921M | 9,4x |
| Amarin Corp Plc\Uk | AMRN | ██% | $302M | -4,5x |
| Amneal Pharmaceuticals, Inc. | AMRX | ██% | $3.95B | 54,8x |
| Anaptysbio, Inc | ANAB | ██% | $1.57B | -2,5x |
| Anebulo Pharmaceuticals, Inc. | ANEB | ██% | $40M | -4,3x |
| Ani Pharmaceuticals Inc | ANIP | ██% | $1.71B | 21,8x |
| Anixa Biosciences Inc | ANIX | ██% | $90M | -15,0x |
| Annexon, Inc. | ANNX | ██% | $806M | -4,1x |
| Alto Neuroscience, Inc. | ANRO | ██% | $688M | -x |
| An2 Therapeutics, Inc. | ANTX | ██% | $125M | -x |
| Annovis Bio, Inc. | ANVS | ██% | $56M | -1,0x |
| Apollomics Inc. | APLM | ██% | $32M | -x |
| Apellis Pharmaceuticals, Inc. | APLS | ██% | $5.11B | 228,4x |
| Applied Therapeutics, Inc. | APLT | ██% | $15M | -0,7x |
| Aprea Therapeutics, Inc. | APRE | ██% | $8M | -1,2x |
| Apimeds Pharmaceuticals Us, … | APUS | ██% | $22M | -x |
| Aptevo Therapeutics Inc. | APVO | ██% | $6M | -0,1x |
| Aquestive Therapeutics, Inc. | AQST | ██% | $501M | -10,7x |
| Arcturus Therapeutics Holdings … | ARCT | ██% | $223M | -7,0x |
| Ardelyx, Inc. | ARDX | ██% | $1.48B | -21,3x |
| Arcutis Biotherapeutics, Inc. | ARQT | ██% | $2.96B | -6,6x |
| Artelo Biosciences, Inc. | ARTL | ██% | $6M | -0,7x |
| Arvinas, Inc. | ARVN | ██% | $685M | -4,8x |
| Arrowhead Pharmaceuticals, Inc. | ARWR | ██% | $8.70B | 43,0x |
| Aspire Biopharma Holdings, … | ASBP | ██% | $5M | -x |
| Assembly Biosciences, Inc. | ASMB | ██% | $461M | -1,5x |
| Ascendis Pharma A/S | ASND | ██% | $14.18B | -x |
| Assertio Holdings, Inc. | ASRT | ██% | $127M | -0,2x |
| Atai Beckley N.V. | ATAI | ██% | $1.34B | -4,4x |
| Alterity Therapeutics Ltd | ATHE | ██% | $67M | -x |
| Actinium Pharmaceuticals, Inc. | ATNM | ██% | $31M | -4,1x |
| Atossa Therapeutics, Inc. | ATOS | ██% | $44M | -6,2x |
| Avenue Therapeutics, Inc. | ATXI | ██% | $1M | -9,5x |
| Astria Therapeutics, Inc. | ATXS | ██% | $710M | -4,7x |
| Aurinia Pharmaceuticals Inc. | AUPH | ██% | $2.05B | 7,1x |
| Arrivent Biopharma, Inc. | AVBP | ██% | $1.03B | -x |
| Avadel Pharmaceuticals Plc | AVDL | ██% | $2.10B | -10,2x |
| Atea Pharmaceuticals, Inc. | AVIR | ██% | $444M | -1,5x |
| Avalo Therapeutics, Inc. | AVTX | ██% | $381M | -0,1x |
| Axim Biotechnologies, Inc. | AXIM | ██% | $2M | -x |
| Axsome Therapeutics, Inc. | AXSM | ██% | $8.75B | -19,9x |
| Aytu Biopharma, Inc | AYTU | ██% | $27M | -0,3x |
| Azitra, Inc. | AZTR | ██% | $4M | -0,2x |
| Bridgebio Pharma, Inc. | BBIO | ██% | $14.50B | -11,6x |
| Bridgebio Oncology Therapeutics, … | BBOT | ██% | $722M | -x |
| Bicara Therapeutics Inc. | BCAX | ██% | $1.33B | -x |
| Briacell Therapeutics Corp. | BCTX | ██% | $29M | -1,7x |
| Bicycle Therapeutics Plc | BCYC | ██% | $340M | -6,0x |
| Bioadaptives, Inc. | BDPT | ██% | $130K | -x |
| Biodexa Pharmaceuticals Plc | BDRX | ██% | $510K | -x |
| Beone Medicines Ltd. | BEIGF | ██% | $36.38B | 530,6x |
| Bullfrog Ai Holdings, … | BFRG | ██% | $14M | -2,9x |
| Biofrontera Inc. | BFRI | ██% | $11M | -0,1x |
| Bio Green Med … | BGMS | ██% | $5M | -x |
| Bausch Health Companies … | BHC | ██% | $2.07B | 13,2x |
| Bioharvest Sciences Inc. | BHST | ██% | $98M | -x |
| Biohaven Ltd. | BHVN | ██% | $1.22B | -4,6x |
| Bioage Labs, Inc. | BIOA | ██% | $787M | -x |
| Bio Essence Corp | BIOE | ██% | $6M | 6,4x |
| Biovie Inc. | BIVI | ██% | $10M | -0,6x |
| Bioxytran, Inc | BIXT | ██% | $5M | -x |
| Biolinerx Ltd. | BLRX | ██% | $10M | -x |
| Belite Bio, Inc | BLTE | ██% | $6.88B | -x |
| Biomea Fusion, Inc. | BMEA | ██% | $108M | -1,6x |
| Biomarin Pharmaceutical Inc | BMRN | ██% | $11.01B | 31,6x |
| Bristol Myers Squibb … | BMY | ██% | $125.56B | 17,8x |
| Bristol Myers Squibb … | BMYMP | ██% | $1.73T | 287,0x |
| Benitec Biopharma Inc. | BNTC | ██% | $376M | -0,6x |
| Boundless Bio, Inc. | BOLD | ██% | $25M | -15,1x |
| Bolt Biotherapeutics, Inc. | BOLT | ██% | $9M | -0,3x |
| Bio-Path Holdings, Inc. | BPTH | ██% | $550K | 0,0x |
| Bioquest Corp | BQST | ██% | $14M | -x |
| Barinthus Biotherapeutics Plc. | BRNS | ██% | $22M | -0,6x |
| Bespoke Extracts, Inc. | BSPK | ██% | $2M | -x |
| Bioxcel Therapeutics, Inc. | BTAI | ██% | $26M | -0,1x |
| Beyondspring Inc. | BYSI | ██% | $69M | 63,8x |
| Calcimedica, Inc. | CALC | ██% | $9M | 0,4x |
| Camp4 Therapeutics Corp | CAMP | ██% | $208M | -0,1x |
| Can-Fite Biopharma Ltd. | CANF | ██% | $7M | -x |
| Capricor Therapeutics, Inc. | CAPR | ██% | $1.73B | -x |
| Carisma Therapeutics Inc. | CARM | ██% | $1M | 0,2x |
| Casi Pharmaceuticals, Inc. | CASI | ██% | $5M | -1,4x |
| Perspective Therapeutics, Inc. | CATX | ██% | $508M | -2,8x |
| Gyre Therapeutics, Inc. | CBIO | ██% | $576M | 58,3x |
| Cdt Equity Inc. | CDT | ██% | $20M | -0,7x |
| Cingulate Inc. | CING | ██% | $70M | -0,6x |
| Cell Source, Inc. | CLCS | ██% | $35M | -x |
| Clene Inc. | CLNN | ██% | $52M | -7,3x |
| Cellectar Biosciences, Inc. | CLRB | ██% | $11M | -x |
| Clearside Biomedical, Inc. | CLSD | ██% | $4M | -2,0x |
| Clearside Biomedical, Inc. | CLSDQ | ██% | $1M | -x |
| Climb Bio, Inc. | CLYM | ██% | $474M | -1,4x |
| Chemomab Therapeutics Ltd. | CMMB | ██% | $11M | 10,9x |
| Clearmind Medicine Inc. | CMND | ██% | $3M | -x |
| Compass Pathways Plc | CMPS | ██% | $725M | 0,0x |
| Cnbx Pharmaceuticals Inc. | CNBX | ██% | $90K | -x |
| Cns Pharmaceuticals, Inc. | CNSP | ██% | $1M | 0,0x |
| Centessa Pharmaceuticals Plc | CNTA | ██% | $5.95B | -11,0x |
| Connect Biopharma Holdings … | CNTB | ██% | $154M | -x |
| Canton Strategic Holdings, … | CNTN | ██% | $167M | -x |
| Context Therapeutics Inc. | CNTX | ██% | $243M | -1,5x |
| Cocrystal Pharma, Inc. | COCP | ██% | $14M | -1,0x |
| Cogent Biosciences, Inc. | COGT | ██% | $5.61B | -3,7x |
| Collegium Pharmaceutical, Inc | COLL | ██% | $1.05B | 16,8x |
| Corcept Therapeutics Inc | CORT | ██% | $4.56B | 45,8x |
| Coya Therapeutics, Inc. | COYA | ██% | $96M | -6,8x |
| China Pharma Holdings, … | CPHI | ██% | $3M | -0,2x |
| Cumberland Pharmaceuticals Inc | CPIX | ██% | $46M | -4,5x |
| Cannapharmarx, Inc. | CPMD | ██% | $3M | -x |
| Catalyst Pharmaceuticals, Inc. | CPRX | ██% | $3.04B | 14,2x |
| Corbus Pharmaceuticals Holdings, … | CRBP | ██% | $176M | -2,0x |
| Cormedix Inc. | CRMD | ██% | $554M | 3,4x |
| Crinetics Pharmaceuticals, Inc. | CRNX | ██% | $3.50B | -15,9x |
| Cervomed Inc. | CRVO | ██% | $37M | -0,7x |
| Corvus Pharmaceuticals, Inc. | CRVS | ██% | $1.21B | -13,7x |
| Cytomx Therapeutics, Inc. | CTMX | ██% | $986M | 29,5x |
| Contineum Therapeutics, Inc. | CTNM | ██% | $504M | -x |
| Citius Oncology, Inc. | CTOR | ██% | $55M | 3,9x |
| Hepion Pharmaceuticals, Inc. | CTRVP | ██% | $20K | -x |
| Citius Pharmaceuticals, Inc. | CTXR | ██% | $19M | -5,3x |
| Cue Biopharma, Inc. | CUE | ██% | $20M | -1,2x |
| Curanex Pharmaceuticals Inc | CURX | ██% | $14M | -x |
| Cadrenal Therapeutics, Inc. | CVKD | ██% | $11M | -11,1x |
| Cv Sciences, Inc. | CVSI | ██% | $6M | -x |
| Cyclerion Therapeutics, Inc. | CYCN | ██% | $24M | -5,2x |
| Cytodyn Inc. | CYDY | ██% | $335M | 86,7x |
| Cypherpunk Technologies Inc. | CYPH | ██% | $63M | 13,1x |
| Cryoport, Inc. | CYRX | ██% | $424M | 5,4x |
| Cytokinetics Inc | CYTK | ██% | $8.20B | -9,4x |
| Dare Bioscience, Inc. | DARE | ██% | $28M | 2,9x |
| Day One Biopharmaceuticals, … | DAWN | ██% | $2.21B | -8,9x |
| Decoy Therapeutics Inc. | DCOY | ██% | $3M | -x |
| Journey Medical Corp | DERM | ██% | $154M | 24,1x |
| Diamedica Therapeutics Inc. | DMAC | ██% | $344M | -4,2x |
| Damora Therapeutics, Inc. | DMRA | ██% | $1.52B | -x |
| Dianthus Therapeutics, Inc. … | DNTH | ██% | $4.48B | -3,2x |
| Dermata Therapeutics, Inc. | DRMA | ██% | $4M | -0,2x |
| Bright Minds Biosciences … | DRUG | ██% | $702M | -x |
| Design Therapeutics, Inc. | DSGN | ██% | $676M | -7,6x |
| Dynavax Technologies Corp | DVAX | ██% | $1.82B | 88,2x |
| Dogwood Therapeutics, Inc. | DWTX | ██% | $71M | -2,9x |
| Dyne Therapeutics, Inc. | DYN | ██% | $2.99B | -7,8x |
| Emergent Biosolutions Inc. | EBS | ██% | $437M | 8,3x |
| Edesa Biotech, Inc. | EDSA | ██% | $46M | -1,3x |
| Eagle Pharmaceuticals, Inc. | EGRX | ██% | $4M | 0,4x |
| Pmgc Holdings Inc. | ELAB | ██% | $8M | -8,2x |
| Elanco Animal Health … | ELAN | ██% | $11.49B | 341,6x |
| Eledon Pharmaceuticals, Inc. | ELDN | ██% | $226M | -x |
| Elite Pharmaceuticals Inc … | ELTP | ██% | $398M | 14,6x |
| Elicio Therapeutics, Inc. | ELTX | ██% | $190M | -1,9x |
| Enliven Therapeutics, Inc. | ELVN | ██% | $2.25B | -13,3x |
| Emmaus Life Sciences, … | EMMA | ██% | $910K | -x |
| Enlivex Ltd. | ENLV | ██% | $230M | 0,1x |
| Ensysce Biosciences, Inc. | ENSC | ██% | $2M | -x |
| Enanta Pharmaceuticals Inc | ENTA | ██% | $376M | -1,3x |
| Gridai Technologies Corp. | ENTO | ██% | $7M | 0,0x |
| Enveric Biosciences, Inc. | ENVB | ██% | $3M | -0,1x |
| Evolus, Inc. | EOLS | ██% | $280M | -13,1x |
| Essa Pharma Inc. | EPIX | ██% | $9M | -2,7x |
| Eupraxia Pharmaceuticals Inc. | EPRX | ██% | $451M | -x |
| Equillium, Inc. | EQ | ██% | $125M | -3,2x |
| Erasca, Inc. | ERAS | ██% | $4.72B | -3,1x |
| Ernexa Therapeutics Inc. | ERNA | ██% | $6M | -x |
| Esperion Therapeutics, Inc. | ESPR | ██% | $670M | -4,2x |
| 89bio, Inc. | ETNB | ██% | $2.20B | -3,5x |
| Eton Pharmaceuticals, Inc. | ETON | ██% | $686M | -66,2x |
| Earth Science Tech, … | ETST | ██% | $26M | 6,5x |
| Evofem Biosciences, Inc. | EVFM | ██% | $1M | 2,7x |
| Evommune, Inc. | EVMN | ██% | $808M | -x |
| Edgewise Therapeutics, Inc. | EWTX | ██% | $3.52B | -19,7x |
| Fuss Brands Corp. | FBDS | ██% | $2M | -x |
| Fortress Biotech, Inc. | FBIO | ██% | $77M | 11,4x |
| Fortress Biotech, Inc. | FBIOP | ██% | $394M | 98,8x |
| Fibrobiologics, Inc. | FBLG | ██% | $5M | -x |
| Forte Biosciences, Inc. | FBRX | ██% | $322M | -11,5x |
| Fibrogen Inc | FGEN | ██% | $35M | 0,2x |
| Foghorn Therapeutics Inc. | FHTX | ██% | $278M | -3,3x |
| Filana Therapeutics, Inc. | FLNA | ██% | $83M | -x |
| Amicus Therapeutics, Inc. | FOLD | ██% | $4.49B | -8,5x |
| Fulcrum Therapeutics, Inc. | FULC | ██% | $498M | -36,1x |
| Galectin Therapeutics Inc | GALT | ██% | $175M | -2,4x |
| Gain Therapeutics, Inc. | GANX | ██% | $82M | -1,4x |
| Generation Bio Co. | GBIO | ██% | $36M | -0,6x |
| Greater Cannabis Company, … | GCAN | ██% | $230K | -x |
| Cytomed Therapeutics Ltd | GDTC | ██% | $12M | -x |
| Geron Corp | GERN | ██% | $1.06B | -11,9x |
| Gh Research Plc | GHRS | ██% | $913M | -x |
| Galmed Pharmaceuticals Ltd. | GLMD | ██% | $3M | -x |
| Galapagos Nv | GLPG | ██% | $1.96B | -x |
| Greenwich Lifesciences, Inc. | GLSI | ██% | $317M | -17,2x |
| Galecto, Inc. | GLTO | ██% | $1.59B | -2,5x |
| Genelux Corp | GNLX | ██% | $115M | -2,8x |
| Genprex, Inc. | GNPX | ██% | $4M | -3,2x |
| Gossamer Bio, Inc. | GOSS | ██% | $85M | -3,2x |
| Geovax Labs, Inc. | GOVX | ██% | $3M | -x |
| Structure Therapeutics Inc. | GPCR | ██% | $3.55B | -44,0x |
| Grace Therapeutics, Inc. | GRCE | ██% | $76M | -3,9x |
| Gridai Technologies Corp. | GRDX | ██% | $8M | -x |
| Gri Bio, Inc. | GRI | ██% | $3M | -0,1x |
| Galera Therapeutics, Inc. | GRTX | ██% | $3M | 0,0x |
| Gsk Plc | GSK | ██% | $112.78B | -x |
| Gt Biopharma, Inc. | GTBP | ██% | $13M | -x |
| Gyre Therapeutics, Inc. | GYRE | ██% | $660M | 66,8x |
| Hutchmed (China) Ltd | HCM | ██% | $2.73B | 3,0x |
| Hcw Biologics Inc. | HCWB | ██% | $2M | -x |
| Cybin Inc. | HELP | ██% | $249M | -x |
| Hepion Pharmaceuticals, Inc. | HEPA | ██% | $640K | -0,1x |
| Vyome Holdings, Inc | HIND | ██% | $15M | -x |
| Hutchmed (China) Ltd | HMDCF | ██% | $2.64B | -x |
| Hookipa Pharma Inc. | HOOK | ██% | $13M | -1,0x |
| Hoth Therapeutics, Inc. | HOTH | ██% | $8M | -0,5x |
| Werewolf Therapeutics, Inc. | HOWL | ██% | $47M | -1,3x |
| Harmony Biosciences Holdings, … | HRMY | ██% | $1.61B | 10,2x |
| Heron Therapeutics, Inc. … | HRTX | ██% | $151M | -6,4x |
| Hst Global, Inc. | HSTC | ██% | $44M | -x |
| Tuhura Biosciences, Inc./Nv | HURA | ██% | $96M | -x |
| Mindwalk Holdings Corp. | HYFT | ██% | $53M | -x |
| Hyperion Defi, Inc. | HYPD | ██% | $28M | -x |
| Ibio, Inc. | IBIO | ██% | $67M | -0,4x |
| Impact Biomedical Inc. | IBO | ██% | $66M | -x |
| Ideaya Biosciences, Inc. | IDYA | ██% | $2.85B | -12,2x |
| Inflarx N.V. | IFRX | ██% | $65M | -x |
| Igc Pharma, Inc. | IGC | ██% | $26M | -4,6x |
| Immutep Ltd | IMMP | ██% | $55M | -x |
| Immix Biopharma, Inc. | IMMX | ██% | $456M | -x |
| Immunome Inc. | IMNM | ██% | $2.54B | -2,4x |
| Imunon, Inc. | IMNN | ██% | $10M | -0,5x |
| Immuron Ltd | IMRN | ██% | $8M | -x |
| Immuneering Corp | IMRX | ██% | $345M | -0,8x |
| Eom Pharmaceutical Holdings, … | IMUC | ██% | $6M | -x |
| Immunic, Inc. | IMUX | ██% | $150M | -0,8x |
| Integrated Biopharma Inc | INBP | ██% | $9M | 14,8x |
| Indaptus Therapeutics, Inc. | INDP | ██% | $4M | -0,6x |
| Indivior Pharmaceuticals, Inc. | INDV | ██% | $3.83B | 18,2x |
| Inmed Pharmaceuticals Inc. | INM | ██% | $2M | -51,8x |
| Inovio Pharmaceuticals, Inc. | INO | ██% | $120M | -0,6x |
| Insmed Inc | INSM | ██% | $35.32B | -14,0x |
| Inhibitor Therapeutics, Inc. | INTI | ██% | $19M | -x |
| Innoviva, Inc. | INVA | ██% | $1.73B | 6,4x |
| Io Biotech, Inc. | IOBT | ██% | $3M | -0,7x |
| Ionis Pharmaceuticals Inc | IONS | ██% | $12.27B | -14,6x |
| Opus Genetics, Inc. | IRD | ██% | $328M | -2,0x |
| Disc Medicine, Inc. | IRON | ██% | $2.45B | -18,4x |
| Ironwood Pharmaceuticals Inc | IRWD | ██% | $636M | 26,5x |
| International Stem Cell … | ISCO | ██% | $1M | -x |
| Iterum Therapeutics Plc | ITRM | ██% | $2M | -0,8x |
| Inventiva S.A. | IVA | ██% | $1.13B | -x |
| Incannex Healthcare Inc. | IXHL | ██% | $41M | -x |
| Jaguar Health, Inc. | JAGX | ██% | $5M | -0,2x |
| Janux Therapeutics, Inc. | JANX | ██% | $876M | -63,7x |
| Jazz Pharmaceuticals Plc | JAZZ | ██% | $11.57B | 14,3x |
| Jade Biosciences, Inc. | JBIO | ██% | $790M | -x |
| Johnson & Johnson | JNJ | ██% | $587.69B | 21,9x |
| Jupiter Neurosciences, Inc. | JUNS | ██% | $14M | -x |
| Kala Bio, Inc. | KALA | ██% | $149M | -0,5x |
| Kalvista Pharmaceuticals, Inc. | KALV | ██% | $1.01B | -2,6x |
| Kairos Pharma, Ltd. | KAPA | ██% | $12M | -x |
| Kaya Holdings, Inc. | KAYS | ██% | $22M | -x |
| Kamada Ltd | KMDA | ██% | $489M | -x |
| Kiniksa Pharmaceuticals International, … | KNSA | ██% | $3.57B | 60,5x |
| Kiora Pharmaceuticals Inc | KPRX | ██% | $7M | -2,4x |
| Karyopharm Therapeutics Inc. | KPTI | ██% | $131M | -0,6x |
| Keros Therapeutics, Inc. | KROS | ██% | $356M | 4,1x |
| Korro Bio, Inc. | KRRO | ██% | $182M | -7,9x |
| Pasithea Therapeutics Corp. | KTTA | ██% | $17M | -73,5x |
| Kura Oncology, Inc. | KURA | ██% | $733M | -4,5x |
| Kyntra Bio, Inc. | KYNB | ██% | $29M | 0,2x |
| Kezar Life Sciences, … | KZR | ██% | $54M | -3,2x |
| Lb Pharmaceuticals Inc | LBRX | ██% | $711M | -x |
| Legend Biotech Corp | LEGN | ██% | $3.52B | -x |
| Lexaria Bioscience Corp. | LEXX | ██% | $22M | -29,3x |
| Lifecore Biomedical, Inc. … | LFCR | ██% | $144M | -x |
| Lifevantage Corp | LFVN | ██% | $54M | 6,8x |
| Ligand Pharmaceuticals Inc | LGND | ██% | $3.95B | 31,7x |
| Longeveron Inc. | LGVN | ██% | $33M | -0,5x |
| Lianbio | LIANY | ██% | $15M | -x |
| Lftd Partners Inc. | LIFD | ██% | $4M | 42,9x |
| Lipella Pharmaceuticals Inc. | LIPO | ██% | $230K | -3,3x |
| Lite Strategy, Inc. | LITS | ██% | $42M | -x |
| Lixte Biotechnology Holdings, … | LIXT | ██% | $27M | -0,9x |
| Lixte Biotechnology Holdings, … | LIXTW | ██% | $130K | -x |
| Eli Lilly & … | LLY | ██% | $856.49B | 41,5x |
| Lunai Bioworks Inc. | LNAI | ██% | $10M | 6,2x |
| Lipocine Inc. | LPCN | ██% | $68M | -2,6x |
| Cypherpunk Technologies Inc. | LPTX | ██% | $94M | -1,1x |
| Liquidia Corp | LQDA | ██% | $3.27B | -7,2x |
| Larimar Therapeutics, Inc. | LRMR | ██% | $486M | -0,8x |
| Lisata Therapeutics, Inc. | LSTA | ██% | $44M | -1,0x |
| Lantern Pharma Inc. | LTRN | ██% | $16M | -2,4x |
| Lava Therapeutics Nv | LVTX | ██% | $46M | -x |
| Lexicon Pharmaceuticals, Inc. | LXRX | ██% | $695M | -1,2x |
| Lyell Immunopharma, Inc. | LYEL | ██% | $442M | -1,1x |
| Maia Biotechnology, Inc. | MAIA | ██% | $81M | -1,4x |
| Mustang Bio, Inc. | MBIO | ██% | $6M | -0,1x |
| Moleculin Biotech, Inc. | MBRX | ██% | $12M | -2,3x |
| Mbx Biosciences, Inc. | MBX | ██% | $1.45B | -x |
| Seres Therapeutics, Inc. | MCRB | ██% | $85M | 14,9x |
| Medicus Pharma Ltd. | MDCX | ██% | $12M | -x |
| Medicus Pharma Ltd. | MDCXW | ██% | $52M | -x |
| Madrigal Pharmaceuticals, Inc. | MDGL | ██% | $12.10B | -5,7x |
| Chrome Holding Co. | MEHCQ | ██% | $96M | -x |
| Macrogenics Inc | MGNX | ██% | $184M | -2,1x |
| Mira Pharmaceuticals, Inc. | MIRA | ██% | $44M | -1,6x |
| Mirum Pharmaceuticals, Inc. | MIRM | ██% | $5.71B | -20,0x |
| Milestone Pharmaceuticals Inc. | MIST | ██% | $139M | -2,0x |
| Moonlake Immunotherapeutics | MLTX | ██% | $1.18B | -50,8x |
| Mineralys Therapeutics, Inc. | MLYS | ██% | $2.15B | -4,5x |
| Mannkind Corp | MNKD | ██% | $782M | 133,4x |
| Medicinova Inc | MNOV | ██% | $70M | -7,1x |
| Monopar Therapeutics | MNPR | ██% | $371M | -3,0x |
| Maplight Therapeutics, Inc. | MPLT | ██% | $945M | -x |
| Mereo Biopharma Group … | MREO | ██% | $53M | -x |
| Merck & Co., … | MRK | ██% | $302.34B | 16,6x |
| Marker Therapeutics, Inc. | MRKR | ██% | $22M | -0,6x |
| Mersana Therapeutics, Inc. | MRSN | ██% | $145M | -3,4x |
| Merus N.V. | MRUS | ██% | $6.83B | -13,5x |
| Maravai Lifesciences Holdings, … | MRVI | ██% | $1.06B | -5,6x |
| Matinas Biopharma Holdings, … | MTNB | ██% | $4M | -1,7x |
| Metsera, Inc. | MTSR | ██% | $7.41B | -x |
| Metavia Inc. | MTVA | ██% | $6M | -0,5x |
| Mural Oncology Plc | MURA | ██% | $35M | -x |
| Mainz Biomed N.V. | MYNZ | ██% | $7M | -x |
| Newamsterdam Pharma Co … | NAMS | ██% | $3.75B | -x |
| Newamsterdam Pharma Co … | NAMSW | ██% | $2.59B | -x |
| Natures Sunshine Products … | NATR | ██% | $428M | 22,0x |
| Nanobiotix S.A. | NBTX | ██% | $1.49B | -x |
| Stablecoin Development Corp | NBY | ██% | $40M | 8,0x |
| Newcelx Ltd. | NCEL | ██% | $11M | -x |
| Nucana Plc | NCNA | ██% | $6M | -x |
| Minerva Neurosciences, Inc. | NERV | ██% | $242M | -0,8x |
| Neuphoria Therapeutics Inc. | NEUP | ██% | $22M | -x |
| Neurogene Inc. | NGNE | ██% | $336M | -7,3x |
| Nika Pharmaceuticals, Inc | NIKA | ██% | $398M | -x |
| Nektar Therapeutics | NKTR | ██% | $2.17B | -1,2x |
| Nkarta, Inc. | NKTX | ██% | $156M | -1,3x |
| Newcelx Ltd. | NLSP | ██% | $54M | -x |
| Newcelx Ltd. | NLSPW | ██% | $120K | -x |
| Nanoviricides, Inc. | NNVC | ██% | $21M | -2,1x |
| Nurix Therapeutics, Inc. | NRIX | ██% | $1.58B | -7,4x |
| Neurosense Therapeutics Ltd. | NRSN | ██% | $25M | -x |
| Nrx Pharmaceuticals, Inc. | NRXP | ██% | $69M | -0,6x |
| Neonc Technologies Holdings, … | NTHI | ██% | $149M | -x |
| Nuvation Bio Inc. | NUVB | ██% | $1.52B | -1,2x |
| Nuvalent, Inc. | NUVL | ██% | $7.68B | -30,9x |
| Nuvectis Pharma, Inc. | NVCT | ██% | $195M | -3,9x |
| Novartis Ag | NVS | ██% | $295.92B | -x |
| Northwest Biotherapeutics Inc | NWBO | ██% | $304M | -x |
| Nexien Biopharma, Inc. | NXEN | ██% | $10K | -x |
| Nextcure, Inc. | NXTC | ██% | $37M | -0,5x |
| Ocean Biomedical, Inc. | OCEA | ██% | $190K | -0,3x |
| Ocular Therapeutix, Inc | OCUL | ██% | $1.80B | -8,2x |
| Oragenics Inc | OGEN | ██% | $2M | -0,1x |
| Organigram Global Inc. | OGI | ██% | $185M | -x |
| Organon & Co. | OGN | ██% | $1.60B | 8,6x |
| Onkure Therapeutics, Inc. | OKUR | ██% | $55M | -6,9x |
| Olema Pharmaceuticals, Inc. | OLMA | ██% | $1.23B | -4,0x |
| Omeros Corp | OMER | ██% | $866M | -4,2x |
| Beone Medicines Ltd. | ONC | ██% | $35.43B | 123,5x |
| Onconetix, Inc. | ONCO | ██% | $1M | -0,3x |
| Oncolytics Biotech Inc | ONCY | ██% | $100M | -x |
| Opko Health, Inc. | OPK | ██% | $849M | -3,5x |
| Organogenesis Holdings Inc. | ORGO | ██% | $293M | 7,9x |
| Orgenesis Inc. | ORGS | ██% | $6M | 0,9x |
| Oric Pharmaceuticals, Inc. | ORIC | ██% | $837M | -4,2x |
| Oruka Therapeutics, Inc. | ORKA | ██% | $2.46B | -x |
| Oramed Pharmaceuticals Inc. | ORMP | ██% | $133M | 2,1x |
| Os Therapies Inc | OSTX | ██% | $50M | -x |
| Oncotelic Therapeutics, Inc. | OTLC | ██% | $18M | -x |
| Ovid Therapeutics Inc. | OVID | ██% | $326M | -2,6x |
| One World Products, … | OWPC | ██% | $750K | -x |
| Phibro Animal Health … | PAHC | ██% | $2.22B | 26,1x |
| Prestige Consumer Healthcare … | PBH | ██% | $2.76B | 14,8x |
| Psyence Biomedical Ltd. | PBM | ██% | $5M | -x |
| Puma Biotechnology, Inc. | PBYI | ██% | $341M | 11,0x |
| Pacira Biosciences, Inc. | PCRX | ██% | $937M | 133,2x |
| Processa Pharmaceuticals, Inc. | PCSA | ██% | $7M | -0,5x |
| Procyon Corp | PCYN | ██% | $2M | -x |
| Pds Biotechnology Corp | PDSB | ██% | $33M | -1,7x |
| Pepgen Inc. | PEPG | ██% | $120M | -1,6x |
| Pfizer Inc | PFE | ██% | $162.25B | 20,9x |
| Precigen, Inc. | PGEN | ██% | $1.39B | -1,4x |
| Phathom Pharmaceuticals, Inc. | PHAT | ██% | $796M | -1,6x |
| Phio Pharmaceuticals Corp. | PHIO | ██% | $15M | -0,8x |
| Pharvaris N.V. | PHVS | ██% | $1.91B | -x |
| Protokinetix, Inc. | PKTX | ██% | $2M | -x |
| Plandai Biotechnology, Inc. | PLPL | ██% | $4M | -x |
| Pliant Therapeutics, Inc. | PLRX | ██% | $81M | -4,5x |
| Polomar Health Services, … | PMHS | ██% | $4M | -x |
| Promis Neurosciences Inc. | PMN | ██% | $117M | -2,1x |
| Pmv Pharmaceuticals, Inc. | PMVP | ██% | $71M | -1,6x |
| Purple Biotech Ltd. | PPBT | ██% | $7M | -x |
| Propanc Biopharma, Inc. | PPCB | ██% | $2M | -x |
| Praxis Precision Medicines, … | PRAX | ██% | $8.04B | -4,0x |
| Prf Technologies Ltd. | PRFX | ██% | $2M | -x |
| Perrigo Co Plc | PRGO | ██% | $1.51B | -27,6x |
| Prelude Therapeutics Inc | PRLD | ██% | $217M | -0,5x |
| Prophase Labs, Inc. | PRPH | ██% | $470K | -0,5x |
| Proqr Therapeutics N.V. | PRQR | ██% | $180M | -x |
| Prothena Corp Public … | PRTA | ██% | $540M | -12,4x |
| Ptc Therapeutics, Inc. | PTCT | ██% | $5.60B | 8,2x |
| Protagonist Therapeutics, Inc | PTGX | ██% | $6.49B | 119,5x |
| Protagenic Therapeutics, Inc.\New | PTIX | ██% | $1M | -2,8x |
| Palatin Technologies Inc | PTN | ██% | $30M | -x |
| Palatin Technologies Inc | PTNT | ██% | $17M | -x |
| Petros Pharmaceuticals, Inc. | PTPI | ██% | $250K | -0,1x |
| Pulmatrix, Inc. | PULM | ██% | $5M | -1,8x |
| Provectus Biopharmaceuticals, Inc. | PVCT | ██% | $20M | -x |
| Palvella Therapeutics, Inc. | PVLA | ██% | $1.72B | -x |
| Pyxis Oncology, Inc. | PYXS | ██% | $92M | -1,3x |
| Aixcrypto Holdings, Inc. | QLGN | ██% | $8M | -1,3x |
| Quoin Pharmaceuticals, Ltd. | QNRX | ██% | $11M | -x |
| Quantum Biopharma Ltd. | QNTM | ██% | $26M | -x |
| Q32 Bio Inc. | QTTB | ██% | $89M | 3,0x |
| Mainz Biomed N.V. | QUCY | ██% | $6M | -x |
| Uniqure N.V. | QURE | ██% | $1.05B | -2,8x |
| Radiopharm Theranostics Ltd | RADX | ██% | $34M | -x |
| Rani Therapeutics Holdings, … | RANI | ██% | $80M | -1,3x |
| Rapport Therapeutics, Inc. | RAPP | ██% | $1.51B | -x |
| Rapt Therapeutics, Inc. | RAPT | ██% | $1.56B | -0,4x |
| Ultragenyx Pharmaceutical Inc. | RARE | ██% | $2.07B | -7,0x |
| Rocket Pharmaceuticals, Inc. | RCKT | ██% | $392M | -4,8x |
| Arcus Biosciences, Inc. | RCUS | ██% | $2.74B | -5,5x |
| Dr Reddys Laboratories … | RDY | ██% | $11.25B | -x |
| Regeneron Pharmaceuticals, Inc. | REGN | ██% | $81.30B | 18,1x |
| Revelation Biosciences, Inc. | REVB | ██% | $5M | -0,1x |
| Rafael Holdings, Inc. | RFL | ██% | $64M | -0,9x |
| Regen Biopharma Inc | RGBP | ██% | $140K | -x |
| Regen Biopharma Inc | RGBPP | ██% | $470K | -x |
| Rigel Pharmaceuticals Inc | RIGL | ██% | $504M | 1,4x |
| Relmada Therapeutics, Inc. | RLMD | ██% | $745M | -0,1x |
| Rallybio Corp | RLYB | ██% | $44M | -0,7x |
| Retrieve Medical Holdings, … | RMHI | ██% | $24M | -x |
| Rockwell Medical, Inc. | RMTI | ██% | $37M | -17,1x |
| Avidity Biosciences, Inc. | RNA | ██% | $206M | -12,2x |
| Cartesian Therapeutics, Inc. | RNAC | ██% | $166M | -2,1x |
| Transcode Therapeutics, Inc. | RNAZ | ██% | $7M | -0,2x |
| Rein Therapeutics, Inc. | RNTX | ██% | $33M | -x |
| Renovorx, Inc. | RNXT | ██% | $46M | -3,4x |
| Roivant Sciences Ltd. | ROIV | ██% | $19.76B | 1,8x |
| Royalty Pharma Plc | RPRX | ██% | $28.05B | 36,4x |
| Repare Therapeutics Inc. | RPTX | ██% | $114M | -2,1x |
| Rest Ez Inc. | RTEZ | ██% | $1.93B | -x |
| Rapid Therapeutic Science … | RTSL | ██% | $110K | 1,9x |
| Reviva Pharmaceuticals Holdings, … | RVPH | ██% | $10M | -4,1x |
| Rhythm Pharmaceuticals, Inc. | RYTM | ██% | $5.92B | -20,3x |
| Rezolute, Inc. | RZLT | ██% | $299M | -3,9x |
| Filana Therapeutics, Inc. | SAVA | ██% | $101M | -1,9x |
| Sunshine Biopharma Inc. | SBFM | ██% | $5M | -0,6x |
| Scienture Holdings, Inc. | SCNX | ██% | $12M | 2,9x |
| Scpharmaceuticals Inc. | SCPH | ██% | $302M | -2,0x |
| Scorpius Holdings, Inc. | SCPX | ██% | $730K | 0,0x |
| Scynexis Inc | SCYX | ██% | $39M | -2,4x |
| Schrodinger, Inc. | SDGR | ██% | $848M | -7,8x |
| Septerna, Inc. | SEPN | ██% | $1.09B | -x |
| Serina Therapeutics, Inc. | SER | ██% | $26M | 22,6x |
| Sagimet Biosciences Inc. | SGMT | ██% | $169M | -x |
| Shuttle Pharmaceuticals Holdings, … | SHPH | ██% | $4M | -x |
| Siga Technologies Inc | SIGA | ██% | $370M | 15,9x |
| Silo Pharma, Inc. | SILO | ██% | $5M | -x |
| Sionna Therapeutics, Inc. | SION | ██% | $1.85B | -x |
| Skinvisible, Inc. | SKVI | ██% | $1M | -x |
| Skye Bioscience, Inc. | SKYE | ██% | $22M | -0,7x |
| Sol-Gel Technologies Ltd. | SLGL | ██% | $271M | -x |
| Silence Therapeutics Plc | SLN | ██% | $258M | -x |
| Silence Therapeutics Plc | SLNCF | ██% | $213M | -x |
| Soleno Therapeutics Inc | SLNO | ██% | $1.93B | 92,6x |
| Salarius Pharmaceuticals, Inc. | SLRX | ██% | $2M | -0,5x |
| Sellas Life Sciences … | SLS | ██% | $756M | -1,0x |
| Summit Therapeutics Inc. | SMMT | ██% | $14.67B | 104,1x |
| Semnur Pharmaceuticals, Inc. | SMNR | ██% | $1.84B | -x |
| Syndax Pharmaceuticals Inc | SNDX | ██% | $2.09B | -4,1x |
| Soligenix, Inc. | SNGX | ██% | $12M | -1,8x |
| Sibannac, Inc. | SNNC | ██% | $990K | -x |
| Sensei Biotherapeutics, Inc. | SNSE | ██% | $44M | -0,4x |
| Sanofi | SNY | ██% | $116.24B | -x |
| Sonnet Biotherapeutics Holdings, … | SONN | ██% | $4M | -1,6x |
| Spruce Biosciences, Inc. | SPRB | ██% | $95M | -0,4x |
| Scisparc Ltd. | SPRC | ██% | $2M | -x |
| Spero Therapeutics, Inc. | SPRO | ██% | $138M | 16,1x |
| Ars Pharmaceuticals, Inc. | SPRY | ██% | $805M | -23,5x |
| Sarepta Therapeutics, Inc. | SRPT | ██% | $2.32B | 162,5x |
| Stoke Therapeutics, Inc. | STOK | ██% | $1.88B | 45,5x |
| Shattuck Labs, Inc. | STTK | ██% | $447M | -x |
| Supernus Pharmaceuticals, Inc. | SUPN | ██% | $2.96B | 46,0x |
| Savara Inc | SVRA | ██% | $1.14B | -8,2x |
| 60 Degrees Pharmaceuticals, … | SXTP | ██% | $5M | -0,6x |
| Synlogic, Inc. | SYBX | ██% | $7M | 3,6x |
| Spyre Therapeutics, Inc. | SYRE | ██% | $3.82B | -0,7x |
| Syros Pharmaceuticals, Inc. | SYRS | ██% | $20K | -0,1x |
| Takeda Pharmaceutical Co … | TAK | ██% | $59.30B | -x |
| Theravance Biopharma, Inc. | TBPH | ██% | $809M | 7,6x |
| Alaunos Therapeutics, Inc. | TCRT | ██% | $7M | -1,0x |
| Telomir Pharmaceuticals, Inc. | TELO | ██% | $45M | -x |
| Tenax Therapeutics, Inc. | TENX | ██% | $275M | -14,9x |
| Terns Pharmaceuticals, Inc. | TERN | ██% | $5.93B | -5,1x |
| Teva Pharmaceutical Industries … | TEVA | ██% | $34.78B | 24,7x |
| Teva Pharmaceutical Industries … | TEVJF | ██% | $38.09B | 53,4x |
| Tg Therapeutics, Inc. | TGTX | ██% | $5.22B | 11,7x |
| Canton Strategic Holdings, … | THAR | ██% | $186M | -x |
| Talphera, Inc. | TLPH | ██% | $38M | -2,3x |
| Telix Pharmaceuticals Ltd | TLX | ██% | $3.13B | -x |
| Tango Therapeutics, Inc. | TNGX | ██% | $2.88B | -2,8x |
| Tonix Pharmaceuticals Holding … | TNXP | ██% | $175M | 0,0x |
| Theriva Biologics, Inc. | TOVX | ██% | $11M | -0,4x |
| Tempest Therapeutics, Inc. | TPST | ██% | $23M | -0,5x |
| Traws Pharma, Inc. | TRAW | ██% | $17M | -0,6x |
| Entrada Therapeutics, Inc. | TRDA | ██% | $516M | 6,9x |
| Trevi Therapeutics, Inc. | TRVI | ██% | $1.49B | -6,1x |
| Trevena Inc | TRVN | ██% | $260K | -1,3x |
| Turn Therapeutics Inc. | TTRX | ██% | $92M | -x |
| Tvardi Therapeutics, Inc. | TVRD | ██% | $28M | -x |
| Travere Therapeutics, Inc. | TVTX | ██% | $2.86B | -x |
| Therapeuticsmd, Inc. | TXMD | ██% | $23M | 538,2x |
| Tyra Biosciences, Inc. | TYRA | ██% | $2.03B | -9,5x |
| Unicycive Therapeutics, Inc. | UNCY | ██% | $179M | -0,9x |
| Upstream Bio, Inc. | UPB | ██% | $503M | -x |
| Urogen Pharma Ltd. | URGN | ██% | $917M | -2,5x |
| United Therapeutics Corp | UTHR | ██% | $24.75B | 18,5x |
| Vaccinex, Inc. | VCNX | ██% | $2M | -0,1x |
| Vera Therapeutics, Inc. | VERA | ██% | $2.59B | -20,4x |
| Veru Inc. | VERU | ██% | $39M | -0,8x |
| Vg Life Sciences … | VGLS | ██% | $4M | -x |
| Vicapsys Life Sciences, … | VICP | ██% | $47M | -x |
| Vincerx Pharma, Inc. | VINC | ██% | $70K | -0,2x |
| Viracta Therapeutics, Inc. | VIRX | ██% | $390K | -0,2x |
| Viking Therapeutics, Inc. | VKTX | ██% | $3.86B | -67,5x |
| Vanda Pharmaceuticals Inc. | VNDA | ██% | $402M | -16,1x |
| Verrica Pharmaceuticals Inc. | VRCA | ██% | $92M | -0,5x |
| Viridian Therapeutics, Inc.\De | VRDN | ██% | $1.92B | -4,5x |
| Vireo Growth Inc. | VREOF | ██% | $348M | -x |
| Verona Pharma Plc | VRNA | ██% | $73.55B | -185,1x |
| Virpax Pharmaceuticals, Inc. | VRPX | ██% | $160K | 0,0x |
| Vertex Pharmaceuticals Inc … | VRTX | ██% | $113.02B | 28,6x |
| Verastem, Inc. | VSTM | ██% | $497M | -6,5x |
| Vistagen Therapeutics, Inc. | VTGN | ██% | $25M | -0,1x |
| Viatris Inc | VTRS | ██% | $15.63B | -29,5x |
| Vtv Therapeutics Inc. | VTVT | ██% | $0.00M | -3,3x |
| Ventyx Biosciences, Inc. | VTYX | ██% | $999M | -1,0x |
| Vyne Therapeutics Inc. | VYNE | ██% | $20M | -0,4x |
| Whitehawk Therapeutics, Inc. | WHWK | ██% | $169M | -x |
| Wave Life Sciences … | WVE | ██% | $1.30B | -22,2x |
| Xenetic Biosciences, Inc. | XBIO | ██% | $6M | -x |
| Xbiotech Inc. | XBIT | ██% | $72M | -3,5x |
| Exicure, Inc. | XCUR | ██% | $26M | -1,9x |
| Xenon Pharmaceuticals Inc. | XENE | ██% | $5.42B | -15,4x |
| Xeris Biopharma Holdings, … | XERS | ██% | $1.01B | 1827,2x |
| Xilio Therapeutics, Inc. | XLO | ██% | $49M | -0,5x |
| Xencor Inc | XNCR | ██% | $907M | -8,4x |
| Xoma Royalty Corp | XOMA | ██% | $393M | 12,4x |
| Xoma Royalty Corp | XOMAO | ██% | $312M | 14,4x |
| Xoma Royalty Corp | XOMAP | ██% | $326M | 15,1x |
| Xtl Biopharmaceuticals Ltd | XTLB | ██% | $6M | -x |
| Zenas Biopharma, Inc. | ZBIO | ██% | $1.12B | -x |
| Zai Lab Ltd | ZLAB | ██% | $2.33B | -95,2x |
| Zentalis Pharmaceuticals, Inc. | ZNTL | ██% | $185M | -1,4x |
| Zomedica Corp. | ZOMDF | ██% | $132M | -x |
| Zoetis Inc. | ZTS | ██% | $50.05B | 18,7x |
| Zevra Therapeutics, Inc. | ZVRA | ██% | $532M | 6,4x |
| Zyversa Therapeutics, Inc. | ZVSA | ██% | $2M | -x |
| Zymeworks Inc. | ZYME | ██% | $1.75B | -8,3x |
Частые вопросы
-
Стоит ли покупать акции Catalyst Pharmaceuticals, Inc.?
Наш ИИ анализирует Catalyst Pharmaceuticals, Inc. ежедневно. Проверьте сигнал выше для последней рекомендации. Всегда проводите собственное исследование перед инвестированием.
-
Насколько точны прогнозы Catalyst Pharmaceuticals, Inc.?
Наш ИИ достигает корреляции Спирмена 14% для этой акции, со средней точностью выше 67% по более чем 4 000 акциям, анализируемым ежедневно.
-
Как часто обновляются прогнозы?
Прогнозы Catalyst Pharmaceuticals, Inc. обновляются ежедневно с использованием последних рыночных данных и ИИ-моделей.
Готовы инвестировать умнее?
Присоединяйтесь к тысячам инвесторов, использующих ИИ-прогнозы акций
Зарегистрироваться бесплатно✓ Бесплатный аккаунт · ✓ Более 4 000 акций · ✓ Ежедневные обновления
Ищете более глубокий анализ Catalyst Pharmaceuticals, Inc.?
Посмотреть полный институциональный анализ на Intratio →ИИ-прогнозы основаны на исторических закономерностях и не должны быть единственным основанием для инвестиционных решений. Прошлые результаты не гарантируют будущих доходов. Всегда проводите собственное исследование.